Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Aug 8:2:62.
doi: 10.3389/fchem.2014.00062. eCollection 2014.

Current challenges in peptide-based drug discovery

Affiliations

Current challenges in peptide-based drug discovery

Laszlo Otvos Jr et al. Front Chem. .
No abstract available

Keywords: grand challenges; oral delivery; peptide drug development; peptides; pharmacodynamics; pharmacokinetics.

PubMed Disclaimer

References

    1. Albert R., Marbach P., Bauer W., Briner U., Fricker G., Bruns C., et al. (1993). SDZ CO 611: a highly potent glycated analog of somatostatin with improved oral activity. Life Sci. 53, 517–525 10.1016/0024-3205(93)90703-6 - DOI - PubMed
    1. Appella E., Padlan E. A., Hunt D. F. (1995). Analysis of the structure of naturally processed peptides bound by class I and class II major histocompatibility complex molecules. Experimentia 73, 105–119 - PubMed
    1. Atkinson T. (2002). Lifestyle drug market booming. Nat. Med. 8, 909 10.1038/nm0902-909 - DOI - PubMed
    1. Boylan N. J., Zhou W., Proos R. J., Tolbert T. J., Wolfe J. L., Laurence J. S. (2013). Conjugation site heterogeneity causes variable electrostatic properties in Fc conjugates. Bioconjug. Chem. 24, 1008–1016 10.1021/bc4000564 - DOI - PMC - PubMed
    1. Carton J. M., Strohl W. R. (2013). Protein therapeutics (Introduction to biopharmaceuticals), in Biological and Small Molecule Drug Research and Development, eds Ganelin R., Jefferts R., Roberts S. (Waltham, MA: Academic Press; ), 127–159